SCHEMBL19081614

SCHEMBL19081614

c1ccc(-c2c3ccccc3c(-c3ccc(-c4ccc5c(c4)oc4c5ccc5c6cc7ccccc7cc6oc54)c4ccccc34)c3ccccc23)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 6/20 0.38
ESR2 Q92731 6/20 0.38
ALOX5 P09917 3/20 0.36
PRKDC P78527 2/20 0.34
MEN1 O00255 1/20 0.33
USP2 O75604 1/20 0.33
POLB P06746 1/20 0.33
KMT2A Q03164 1/20 0.33
ATM Q13315 1/20 0.33
PLEC Q15149 1/20 0.33
DYRK1A Q13627 1/20 0.33
ERAP1 Q9NZ08 1/20 0.33
CYP1A2 P05177 3/20 0.32
CYP1A1 P04798 2/20 0.32
CYP1B1 Q16678 2/20 0.32
ALDH1A1 P00352 2/20 0.32
CYP2C9 P11712 2/20 0.32
CYP2C19 P33261 2/20 0.32
GPR84 Q9NQS5 2/20 0.32
KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17931956 0.93 ESR1 (0.41) ESR1ESR2ALOX5MEN1USP2
SCHEMBL19076402 0.91 ALOX5 (0.40) ESR1ESR2ALOX5PRKDCMEN1
SCHEMBL19080021 0.90 CYP1A1 (0.40) ESR1ESR2ALOX5PRKDCCYP1A2
SCHEMBL17932158 0.89 ALOX5 (0.46) ALOX5PRKDCMEN1USP2POLB
SCHEMBL19080020 0.89 CYP1A1 (0.41) ESR1ESR2PRKDCCYP1A2CYP1A1
SCHEMBL20053302 0.89 ESR1 (0.38) ESR1ESR2ALOX5MEN1USP2
SCHEMBL17932076 0.88 ESR1 (0.39) ESR1ESR2ALOX5PRKDCMEN1
SCHEMBL17931955 0.88 CYP1A1 (0.44) ALOX5PRKDCKMT2ADYRK1ACYP1A2
SCHEMBL17931905 0.88 ESR1 (0.38) ESR1ESR2ALOX5MEN1USP2
SCHEMBL19081522 0.87 ESR1 (0.40) ESR1ESR2ALOX5PRKDCDYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 ESR1 225/4885ESR2 542/4885ALOX5 1939/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 ESR1 225/4885ESR2 542/4885ALOX5 1939/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.